Investerarrelationer Kontakt
Investor Relations
Klaus Sindahl
Head of Investor Relations
Mobilnummer: +46 (0) 709 298 269
E-mail: klaus.sindahl@hansabiopharma.com
Klaus Sindahl
Head of Investor Relations
Mobilnummer: +46 (0) 709 298 269
E-mail: klaus.sindahl@hansabiopharma.com